Search
for
Sort by
Research 91–120 of 1000+
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Overview of the Role of 308 Monochromatic Excimer Phototherapy for the Treatment of Alopecia Areata
- Topical finasteride 0.25% in HPCH spray for androgenetic alopecia: a single-center retrospective study
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Clinical and demographic factors associated with nail involvement in adult alopecia areata patients at Al-Kadhmia teaching hospital, Baghdad, 2023
- A Review on Hydrogels with Photothermal Effect in Wound Healing and Bone Tissue Engineering
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Therapeutic Efficacy and Safety of Platelet-Rich Plasma (PRP) for Hair Restoration: A Narrative Review
- MICRONEEDLING WITH PLATELET-RICH PLASMA VERSUS MICRONEEDLING WITH TOPICAL 5% MINOXIDIL IN PATIENTS WITH ANDROGENETIC ALOPECIA- A COMPARATIVE STUDY
- Cannabinoids for the Treatment of Hair, Scalp, and Skin Disorders: A Systematic Review
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Autoinmune Alopecia/Alopecia Areata
- Retinoid Metabolism Is Altered in Human and Mouse Cicatricial Alopecia
- Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
- Is Intralesional Methotrexate an Effective Alternative to Intralesional Triamcinolone in Alopecia Areata? Findings From a Randomized Controlled Trial
- 1318 Both lesional and non-lesional skin from acne patients shows robust IL-17-skewing and upregulation of antimicrobial peptides
- Efficacy and safety of superficial cryotherapy for alopecia areata: A retrospective, comprehensive review of 353 cases over 22 years
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata